Studies from humans and animal models have demonstrated that adiponectin expression is reduced in obesity [7, 8], whereas the expressional change of resistin in obesity is still in controversy owing to the influence of several factors such as types of body fat deposition (central or subcutaneous), genetic background, and gender [9, 10]. Here, RETN is linked to obesity disorder.